Shuwen Biotech Co Ltd - Product Pipeline Analysis, 2018 Update
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Shuwen Biotech Co Ltd Company Overview 5
Shuwen Biotech Co Ltd Company Snapshot 5
Shuwen Biotech Co Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Shuwen Biotech Co Ltd – Pipeline Analysis Overview 8
Shuwen Biotech Co Ltd - Key Facts 8
Shuwen Biotech Co Ltd - Major Products and Services 9
Shuwen Biotech Co Ltd Pipeline Products by Development Stage 10
Shuwen Biotech Co Ltd Pipeline Products Overview 12
CapCord Preeclampsia Detection Kit 12
CapCord Preeclampsia Detection Kit Product Overview 12
Colorectal Cancer Theranostic Test 13
Colorectal Cancer Theranostic Test Product Overview 13
Companion Diagnostic (CDx) Kit 14
Companion Diagnostic (CDx) Kit Product Overview 14
Companion Diagnostic Assay - Cancer 15
Companion Diagnostic Assay - Cancer Product Overview 15
Diagnostic Test - Infectious Diseases 16
Diagnostic Test - Infectious Diseases Product Overview 16
Diagnostic Test - Neurological Diseases 17
Diagnostic Test - Neurological Diseases Product Overview 17
Diagnostic Test - Autoimmune Diseases 18
Diagnostic Test - Autoimmune Diseases Product Overview 18
Diagnostic Test - Urological Disorders 19
Diagnostic Test - Urological Disorders Product Overview 19
FGFR1 FISH Gene Amplification Detection Kit - Lung Cancer 20
FGFR1 FISH Gene Amplification Detection Kit - Lung Cancer Product Overview 20
FGFR1 Gene Amplification Detection FISH Kit - Breast Cancer 21
FGFR1 Gene Amplification Detection FISH Kit - Breast Cancer Product Overview 21
FGFR1 Gene Amplification Detection QPCR Kit - Breast Cancer 22
FGFR1 Gene Amplification Detection QPCR Kit - Breast Cancer Product Overview 22
FGFR1 QPCR Gene Amplification Detection Kit - Lung Cancer 23
FGFR1 QPCR Gene Amplification Detection Kit - Lung Cancer Product Overview 23
Microsatellite Instability (MSI) Assay Kit - Colorectal Cancer 24
Microsatellite Instability (MSI) Assay Kit - Colorectal Cancer Product Overview 24
PIK3CA Mutation Analysis Kit - Colorectal Cancer 25
PIK3CA Mutation Analysis Kit - Colorectal Cancer Product Overview 25
PIK3CA Mutation Analysis Kit - Lung Cancer 26
PIK3CA Mutation Analysis Kit - Lung Cancer Product Overview 26
PIK3CA Mutation Analysis Real-Time PCR Kit - Breast Cancer 27
PIK3CA Mutation Analysis Real-Time PCR Kit - Breast Cancer Product Overview 27
RPS Gene Expression Signature Kit - Breast Cancer 28
RPS Gene Expression Signature Kit - Breast Cancer Product Overview 28
Shuwen Biotech Co Ltd - Key Competitors 29
Shuwen Biotech Co Ltd - Key Employees 30
Shuwen Biotech Co Ltd - Locations And Subsidiaries 31
Head Office 31
Recent Developments 32
Shuwen Biotech Co Ltd, Recent Developments 32
Jul 19, 2018: Shuwen Biotech’s clinical lab successfully passes Biyearly College of American Pathologists audit 32
May 16, 2018: Shuwen Debuts it’s CODAR-ARMS PCR Liquid Biopsy Technology at ASCO 2018 32
Apr 26, 2018: Abcam and Shuwen Biotech sign strategic MoU to establish global alliance for companion diagnostic (CDx) kit development 32
Sep 18, 2017: Shuwen Biotech Receives CE Mark for EGFR Mutation PCR Kit for Lung Cancer 33
Jan 13, 2017: Shuwen Biotech Receives EN ISO 13485 Certification 33
Jun 30, 2015: Shuwen Biotech Appoints Recognized Leader in Urologic Pathology to Advisory Board 33
Feb 25, 2015: Diagnostic Industry Veteran Gregory C. Critchfield Joins Shuwen Biotech’s Advisory Board 33
Dec 11, 2014: Shuwen Biotech Receives License to Operate New Diagnostic Reference Lab in China and Forms New Subsidiary for the Lab 34
Oct 05, 2014: Shuwen Biotech Enters into Collaboration and Clinical Trial Agreement with Shanghai First Maternity and Infant Hospital 34
Jul 05, 2014: Shuwen Biotech Appoints Saaras Hu as Laboratory Director 35
Appendix 36
Methodology 36
About GlobalData 39
Contact Us 39
Disclaimer 39
Summary
Shuwen Biotech Co Ltd (Shuwen Biotech) is a medical equipment company. The company develops diagnostic products and services for disease prevention, diagnosis and personalized medicine. It offers in-vitro diagnostic (IVD) kits for oncology and pregnancy-related conditions. Shuwen Biotech develops tests for predisposition, screening, diagnosis, classification, prognosis, theranostics and therapeutic monitoring. The company’s kits are used for the diagnosis of breast cancer, lung cancer, colorectal cancer, urology, autoimmune diseases, neurological diseases and infectious diseases. It also provides laboratory developed test (LDT) and clinical testing services such as mammatyper breast cancer molecular subtyping, epidermal growth factor receptor (EGFR) mutation analysis, KRAS mutation analysis, BRAF mutation analysis, EML4-ALK fusion analysis, and PIK3CA mutation analysis. The company provides clinical services such as PD-L1 IHC testing, esoteric clinical chemistry tests, esoteric immunological tests, MTFHR genotyping for folic acid supplementation, and N9 nutrigenetic testing. Shuwen Biotech is headquartered in Huzhou, China.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Shuwen Biotech Co Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company